awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q42755954-0FC0BBC6-0549-4AF7-AB61-D7B164F29DA8
Q42755954-0FC0BBC6-0549-4AF7-AB61-D7B164F29DA8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42755954-0FC0BBC6-0549-4AF7-AB61-D7B164F29DA8
Overcoming Resistance to Endocrine Therapy in Breast Cancer: New Approaches to a Nagging Problem.
P2860
Q42755954-0FC0BBC6-0549-4AF7-AB61-D7B164F29DA8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42755954-0FC0BBC6-0549-4AF7-AB61-D7B164F29DA8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b219a2b237119fc3a1ed76c94bd3959801d88cf5
P2860
A phase II study of combined fulvestrant and everolimus in patients with metastatic estrogen receptor (ER)-positive breast cancer after aromatase inhibitor (AI) failure.